Abstract:Four different molecular subgroups are recognized in medulloblastoma (MB). Among these subgroups, Group 3 and 4 tumors are the most aggressive malignancies with few effective therapies. New therapies are likely to be most effective if they target molecular alterations that mediate the formation and growth of these malignancies.
We searched the public cancer microarray database Oncomine and found that the expression of OTX2, c-Myc, polycomb repressor complex 2 (PRC2) subunits EZH2 and SuZ12 are s… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.